These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6954482)

  • 1. 1,25-Dihydroxyvitamin D3: short- and long-term effects on bone and calcium metabolism in patients with postmenopausal osteoporosis.
    Gallagher JC; Jerpbak CM; Jee WS; Johnson KA; DeLuca HF; Riggs BL
    Proc Natl Acad Sci U S A; 1982 May; 79(10):3325-9. PubMed ID: 6954482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of long term treatment with calcitriol on calcium absorption and mineral metabolism in postmenopausal osteoporosis.
    Riggs BL; Nelson KI
    J Clin Endocrinol Metab; 1985 Sep; 61(3):457-61. PubMed ID: 3926808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hormonal form of vitamin D in the pathophysiology and therapy of postmenopausal osteoporosis.
    Caniggia A; Nuti R; Loré F; Vattimo A
    J Endocrinol Invest; 1984 Aug; 7(4):373-8. PubMed ID: 6094649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of sodium fluoride, calcium phosphate, and vitamin D2 for one to two years on calcium and phosphorus metabolism in postmenopausal women with spinal crush fracture osteoporosis.
    Charles P; Mosekilde L; Jensen FT
    Bone; 1985; 6(4):201-6. PubMed ID: 3876838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcitriol in the treatment of postmenopausal osteoporosis.
    Aloia JF; Vaswani A; Yeh JK; Ellis K; Yasumura S; Cohn SH
    Am J Med; 1988 Mar; 84(3 Pt 1):401-8. PubMed ID: 3279769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium metabolism and osteoporosis in corticosteroid-treated postmenopausal women.
    Need AG; Philcox JC; Hartley TF; Nordin BE
    Aust N Z J Med; 1986 Jun; 16(3):341-6. PubMed ID: 3465310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, biochemical and histological results of a double-blind trial with 1,25-dihydroxyvitamin D3, estradiol and placebo in post-menopausal osteoporosis.
    Caniggia A; Delling G; Nuti R; Lorè F; Vattimo A
    Acta Vitaminol Enzymol; 1984; 6(2):117-28. PubMed ID: 6388277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a long-term treatment with 1,25-dihydroxyvitamin D3 on osteocalcin in postmenopausal osteoporosis.
    Caniggia A; Nuti R; Galli M; Loré F; Turchetti V; Righi GA
    Calcif Tissue Int; 1986 Jun; 38(6):328-32. PubMed ID: 3089554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis.
    Gallagher JC; Riggs BL; DeLuca HF
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1359-64. PubMed ID: 6255005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction in intestinal calcium absorption by hydrochlorothiazide in postmenopausal osteoporosis.
    Sakhaee K; Nicar MJ; Glass K; Zerwekh JE; Pak CY
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1037-43. PubMed ID: 6490791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of patients with postmenopausal osteoporosis and steroid-induced osteoporosis with the preparation Rocaltrol (1,25/OH/2 vitamin D3)].
    Koev D; Todorova S; Diankov L; Khristova D; Tsachev K
    Vutr Boles; 1988; 27(2):117-22. PubMed ID: 3414094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dietary sodium chloride loading on parathyroid function, 1,25-dihydroxyvitamin D, calcium balance, and bone metabolism in female rats during chronic prednisolone administration.
    Goulding A; Gold E
    Endocrinology; 1986 Nov; 119(5):2148-54. PubMed ID: 3769866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,25-Dihydroxycalciferol and calcium therapy in osteoporosis with calcium malabsorption. Dose response relationship of calcium absorption and indices of bone turnover.
    Need AG; Horowitz M; Philcox JC; Nordin BE
    Miner Electrolyte Metab; 1985; 11(1):35-40. PubMed ID: 3838358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ability of 25-hydroxyvitamin D3 therapy to augment serum 1,25- and 24,25-dihydroxyvitamin D in postmenopausal osteoporosis.
    Lawoyin S; Zerwekh JE; Glass K; Pak CY
    J Clin Endocrinol Metab; 1980 Mar; 50(3):593-6. PubMed ID: 6965678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nandrolone decanoate on forearm mineral density and calcium metabolism in osteoporotic postmenopausal women.
    Need AG; Morris HA; Hartley TF; Horowitz M; Nordin BE
    Calcif Tissue Int; 1987 Jul; 41(1):7-10. PubMed ID: 3113703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiological mechanisms of estrogen effect on bone metabolism. Dose-response relationships in early postmenopausal women.
    Christiansen C; Christensen MS; Larsen NE; Transbøl IB
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1124-30. PubMed ID: 7130340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved mineral balance and skeletal metabolism in postmenopausal women treated with potassium bicarbonate.
    Sebastian A; Harris ST; Ottaway JH; Todd KM; Morris RC
    N Engl J Med; 1994 Jun; 330(25):1776-81. PubMed ID: 8190153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium and calcitriol therapy in osteoporotic postmenopausal women with impaired calcium absorption.
    Need AG; Nordin C; Horowitz M; Morris HA
    Metabolism; 1990 Apr; 39(4 Suppl 1):53-4. PubMed ID: 2325573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of calcium supplementation on urinary hydroxyproline in osteoporotic postmenopausal women.
    Horowitz M; Need AG; Philcox JC; Nordin BE
    Am J Clin Nutr; 1984 Jun; 39(6):857-9. PubMed ID: 6720619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonates for prevention of postmenopausal osteoporosis.
    Ravn P
    Dan Med Bull; 2002 Feb; 49(1):1-18. PubMed ID: 11894721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.